ImmuCell Corporation
$9.92
+0.13 (+1.33%)
Price as of Sep 01, 2026 market close
Performance
- 1 Month
- -10.1%
- 3 Months
- +1.3%
- YTD
- +61.3%
- 1 Year
- +55.0%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 52.3%
- Largest decline max drawdown, since Aug 2025
- -32.9%
- Risk-adjusted return Sharpe ratio, 1-year
- 1.10
Own ICCC?
See how ICCC contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.